NICE technology appraisal guidance
Issued: August 2011
TA233
Golimumab for the treatment of ankylosing spondylitis
This is an extract from the guidance. The complete guidance is available at guidance.nice.org.uk/ta233
Important information about this guidance
This guidance was developed using the NICE single technology appraisals process: www.nice.org.uk/aboutnice/howwework/devnicetech/developing_nice_technology_appraisals.jsp